SCHEMBL19908690

SCHEMBL19908690

C=C(N)c1ccc(C)cc1C

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.44
TP53 P04637 2/20 0.44
NFE2L2 Q16236 1/20 0.40
ALDH1A1 P00352 3/20 0.39
PRSS1 P07477 1/20 0.39
PRSS2 P07478 1/20 0.39
PRSS3 P35030 1/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
HTT P42858 2/20 0.39
KMT2A Q03164 2/20 0.39
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
TNF P01375 1/20 0.38
PKM P14618 1/20 0.38
CDK5 Q00535 1/20 0.38
KLF5 Q13887 1/20 0.38
CDK5R1 Q15078 1/20 0.38
NOD1 Q9Y239 1/20 0.38
HSD11B1 P28845 1/20 0.38
ALOX15 P16050 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17934412 0.82 CYP2D6 (0.46) TDP1TP53ALDH1A1PRSS1PRSS2
SCHEMBL6547363 0.81 TDP1 (0.48) TDP1TP53NFE2L2ALDH1A1SMN1; SMN2
SCHEMBL29883022 0.81 TDP1 (0.48) TDP1TP53NFE2L2ALDH1A1SMN1; SMN2
SCHEMBL10873220 0.80 ALDH1A1 (0.50) TDP1TP53ALDH1A1SMN1; SMN2HTT
SCHEMBL11300977 0.79 TDP1 (0.46) TDP1TP53NFE2L2ALDH1A1SMN1; SMN2
SCHEMBL674175 0.79 TDP1 (0.46) TDP1TP53NFE2L2ALDH1A1SMN1; SMN2
SCHEMBL29444190 0.79 TDP1 (0.46) TDP1TP53NFE2L2ALDH1A1SMN1; SMN2
SCHEMBL23978126 0.77 TDP1 (0.44) TDP1TP53NFE2L2ALDH1A1SMN1; SMN2
SCHEMBL2107802 0.77 PRSS1 (0.48) TDP1TP53NFE2L2ALDH1A1PRSS1
SCHEMBL11601038 0.77 TDP1 (0.44) TDP1TP53NFE2L2ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4306529-A2 FGFR INHIBITORS AND METHODS OF USE THEREOF Relay Therapeutics, Inc. (US) 2024-01-17 EP disclosed
WO-2020102100-A9 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS AG (CH) 2022-01-06 WO disclosed
EP-2598946-B1 POLYMERIZABLE COMPOSITION FUJIFILM CORP (JP) 2019-04-03 EP disclosed
EP-3287441-A1 HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2018-02-28 EP disclosed